Concepedia

Meng Xiao He

MX

Statistics

Publications

40

Citations

4.8K

H-Index

27

Active since

2014

Affiliations

Dana-Farber Cancer Institute(Current)

Broad Institute

Harvard University

University of Wollongong

Brigham and Women's Hospital

Meng Xiao He is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2014–2023

40

Publications

40

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

David Liu, Bastian Schilling, Derek Liu et al. · Nature Medicine · 2019 · 1.1K citations · Full text

, , +17

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Kevin Bi, Meng Xiao He, Ziad Bakouny et al. · Cancer Cell · 2021 · 628 citations · Full text

, , +17

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations

, , +17

Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma

Oksana Zavidij, Nicholas J. Haradhvala, Tarek H. Mouhieddine et al. · Nature Cancer · 2020 · 358 citations · Full text

, , +17

Intron retention is a source of neoepitopes in cancer

Alicia Smart, Claire A. Margolis, Harold Pimentel et al. · Nature Biotechnology · 2018 · 339 citations

, , +9

1–5 of 40